Skip to main content
. 2017 Dec 10;9(1):662–667. doi: 10.18632/oncotarget.23087

Figure 1.

Figure 1

(A) Difference in serum ESM-1 level between RCC patients and control subjects. (B) ROC curve for serum ESM-1 comparing RCC patients (n = 56) and control subjects (n = 56). The AUC for serum ESM-1 was 0.721 (95% CI, 0.628–0.817).